Results 11 to 20 of about 116,695 (299)

Antifungal resistance in dermatology [PDF]

open access: yesIndian Journal of Dermatology, 2018
Cutaneous fungal infections affect more than one-fourth of world's population. The pathogenesis and severity of fungal infection depend on various immunological and nonimmunological factors.
Varadraj Pai   +2 more
doaj   +4 more sources

Antifungal Use and Resistance in a Lower–Middle-Income Country: The Case of Lebanon [PDF]

open access: yesAntibiotics, 2023
Antimicrobial resistance is a serious threat, particularly in low- and middle-income countries (LMICs). Antifungal resistance is often underestimated in both healthcare and non-clinical settings.
Nesrine Hassoun   +5 more
doaj   +2 more sources

Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review

open access: yesAntibiotics, 2023
Fungal infections are becoming one of the main causes of morbidity and mortality in people with weakened immune systems. Mycoses are becoming more common, despite greater knowledge and better treatment methods, due to the regular emergence of resistance ...
Ali A. Rabaan   +19 more
doaj   +3 more sources

Resistance to antifungal therapies [PDF]

open access: yesEssays in Biochemistry, 2017
The evolution of antifungal resistance among fungal pathogens has rendered the limited arsenal of antifungal drugs futile. Considering the recent rise in the number of nosocomial fungal infections in immunocompromised patients, the emerging clinical multidrug resistance (MDR) has become a matter of grave concern for medical professionals.
Rajendra, Prasad   +2 more
openaire   +3 more sources

Antifungal resistance in superficial mycoses [PDF]

open access: yesJournal of Dermatological Treatment, 2021
With the widespread use of antifungals to treat superficial mycoses, reports of antifungal resistance are increasing. Antifungal resistance is becoming a public health challenge and needs to be addressed in parallel with antibacterial and antiviral resistance.We review the growing resistance of fungal pathogens such as Trichophyton species and the ...
Aditya K, Gupta, Maanasa, Venkataraman
openaire   +3 more sources

Epigenetic Regulation of Antifungal Drug Resistance [PDF]

open access: yesJournal of Fungi, 2022
In medical mycology, epigenetic mechanisms are emerging as key regulators of multiple aspects of fungal biology ranging from development, phenotypic and morphological plasticity to antifungal drug resistance.
Sandip Patra   +3 more
doaj   +2 more sources

Antifungal Resistance Patterns of Oral and Intestinal Candida Isolates Among People Living with HIV in a Tertiary Hospital in Gabon: A Cross-Sectional Study [PDF]

open access: yesMicroorganisms
Digestive candidiasis is a major opportunistic infection among people living with HIV (PLHIV). In Gabon, data on antifungal resistance remain limited. This study aimed to characterise Candida colonisation and antifungal resistance according to anatomical
Geril Sekangue Obili   +7 more
doaj   +2 more sources

Candida Species Biofilms’ Antifungal Resistance [PDF]

open access: yesJournal of Fungi, 2017
Candida infections (candidiasis) are the most prevalent opportunistic fungal infection on humans and, as such, a major public health problem. In recent decades, candidiasis has been associated to Candida species other than Candida albicans.
Sónia Silva   +4 more
doaj   +4 more sources

Antifungal resistance on Sporothrix species: an overview [PDF]

open access: yesBrazilian Journal of Microbiology, 2020
The treatment of human and animal sporotrichosis is often performed with antifungal agents; however, the emergence of antifungal-resistant strains of Sporothrix species has been reported. We aimed to discuss the ability of Sporothrix species in developing resistance to the conventional antifungals and mechanisms for this.Published data on databases ...
Stefanie Bressan Waller   +5 more
openaire   +5 more sources

Antifungal Resistance in Cryptococcal Infections [PDF]

open access: yesPathogens
Antifungal therapy, especially with the azoles, could promote the incidence of less susceptible isolates of Cryptococcus neoformans and C. gattii species complexes (SC), mostly in developing countries. Given that these species affect mostly the immunocompromised host, the infections are severe and difficult to treat.
Marcia S. C. Melhem   +10 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy